Citations (421)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (24)
Mônica Villa Nova, Kennard Gan & Matthias G. Wacker. (2022) Biopredictive tools for the development of injectable drug products. Expert Opinion on Drug Delivery 19:6, pages 671-684.
Read now
Read now
Arjen Koppen, Claudine C. Hunault, Regina G. D. M. van Kleef, Agnes G. van Velzen, Remco H. S. Westerink, Irma de Vries & Dylan W. de Lange. (2022) Estimation of the risk of local and systemic effects in infants after ingestion of low-concentrated weak acids from descaling products. Clinical Toxicology 60:1, pages 71-75.
Read now
Read now
Miyuki Breen, Caroline L Ring, Anna Kreutz, Michael-Rock Goldsmith & John F Wambaugh. (2021) High-throughput PBTK models for in vitro to in vivo extrapolation. Expert Opinion on Drug Metabolism & Toxicology 17:8, pages 903-921.
Read now
Read now
Shin-ichiro Ogawa, Makiko Shimizu & Hiroshi Yamazaki. (2020) Modelled plasma concentrations of pemafibrate with co-administered typical cytochrome P450 inhibitors clopidogrel, fluconazole or clarithromycin predicted by physiologically based pharmacokinetic modelling in virtual populations. Xenobiotica 50:12, pages 1413-1422.
Read now
Read now
Shin-ichiro Ogawa, Makiko Shimizu & Hiroshi Yamazaki. (2020) Plasma concentrations of pemafibrate with co-administered drugs predicted by physiologically based pharmacokinetic modeling in virtual populations with renal/hepatic impairment. Xenobiotica 50:9, pages 1023-1031.
Read now
Read now
Kentaro Konishi, Tsuyoshi Minematsu, Yasuhisa Nagasaka & Kenji Tabata. (2019) Physiologically-based pharmacokinetic modeling for mirabegron: a multi-elimination pathway mediated by cytochrome P450 3A4, uridine 5'-diphosphate-glucuronosyltransferase 2B7, and butyrylcholinesterase. Xenobiotica 49:8, pages 912-921.
Read now
Read now
Laura Hedges, Susan Brown, A. Kenneth MacLeod, Audrey Vardy, Edward Doyle, Gina Song, Marjory Moreau, Miyoung Yoon, Thomas G. Osimitz & Brian G. Lake. (2019) Metabolism of deltamethrin and cis- and trans-permethrin by human expressed cytochrome P450 and carboxylesterase enzymes. Xenobiotica 49:5, pages 521-527.
Read now
Read now
Beth Williamson & Robert J. Riley. (2017) Hepatic transporter drug-drug interactions: an evaluation of approaches and methodologies. Expert Opinion on Drug Metabolism & Toxicology 13:12, pages 1237-1250.
Read now
Read now
Satomi Shida, Masahiro Utoh, Norie Murayama, Makiko Shimizu, Yasuhiro Uno & Hiroshi Yamazaki. (2015) Human plasma concentrations of cytochrome P450 probes extrapolated from pharmacokinetics in cynomolgus monkeys using physiologically based pharmacokinetic modeling. Xenobiotica 45:10, pages 881-886.
Read now
Read now
Darren Michael Moss, Catia Marzolini, Rajith KR Rajoli & Marco Siccardi. (2015) Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies. Expert Opinion on Drug Metabolism & Toxicology 11:8, pages 1203-1217.
Read now
Read now
Jia Chen, Dongyang Liu, Xin Zheng, Qian Zhao, Ji Jiang & Pei Hu. (2015) Relative contributions of the major human CYP450 to the metabolism of icotinib and its implication in prediction of drug–drug interaction between icotinib and CYP3A4 inhibitors/inducers using physiologically based pharmacokinetic modeling. Expert Opinion on Drug Metabolism & Toxicology 11:6, pages 857-868.
Read now
Read now
Robert J Riley & Claire E Wilson. (2015) Cytochrome P450 time-dependent inhibition and induction: advances in assays, risk analysis and modelling. Expert Opinion on Drug Metabolism & Toxicology 11:4, pages 557-572.
Read now
Read now
Cyrielle Dumont, Marylore Chenel & France Mentré. (2014) Influence of Covariance Between Random Effects in Design for Nonlinear Mixed-Effect Models with an Illustration in Pediatric Pharmacokinetics. Journal of Biopharmaceutical Statistics 24:3, pages 471-492.
Read now
Read now
Hugh A Barton, Yurong Lai, Theunis C Goosen, Hannah M Jones, Ayman F El-Kattan, James R Gosset, Jian Lin & Manthena V Varma. (2013) Model-based approaches to predict drug–drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond. Expert Opinion on Drug Metabolism & Toxicology 9:4, pages 459-472.
Read now
Read now
Miyoung Yoon, Jerry L. Campbell, Melvin E. Andersen & Harvey J. Clewell. (2012) Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results. Critical Reviews in Toxicology 42:8, pages 633-652.
Read now
Read now
Mario Pellegatti. (2012) Preclinical in vivo ADME studies in drug development: a critical review. Expert Opinion on Drug Metabolism & Toxicology 8:2, pages 161-172.
Read now
Read now
Anthony Harrison, Iain Gardner, Tanya Hay, Maurice Dickins, Kevin Beaumont, Alex Phipps, Lynn Purkins, Gill Allan, Rachelle Christian, Jonathan Duckworth, Ian Gurrell, Sarah Kempshall, Mark Savage, Mark Seymour, Marie Simpson, Louise Taylor & Paul Turnpenny. (2012) Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigms. Xenobiotica 42:1, pages 57-74.
Read now
Read now
Helen E. Cubitt, Karen R. Yeo, Eleanor M. Howgate, Amin Rostami-Hodjegan & Zoe E. Barter. (2011) Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model. Xenobiotica 41:8, pages 623-638.
Read now
Read now
Jianling Wang & Alan Collis. (2011) Maximizing the outcome of early ADMET models: strategies to win the drug-hunting battles?. Expert Opinion on Drug Metabolism & Toxicology 7:4, pages 381-386.
Read now
Read now
Chao Xu & Donald E Mager. (2011) Quantitative structure–pharmacokinetic relationships. Expert Opinion on Drug Metabolism & Toxicology 7:1, pages 63-77.
Read now
Read now
Odette A Fahmi & Sharon L Ripp. (2010) Evaluation of models for predicting drug–drug interactions due to induction. Expert Opinion on Drug Metabolism & Toxicology 6:11, pages 1399-1416.
Read now
Read now
Elaine
A. Cohen Hubal, Ann Richard, Lesa Aylward, Steve Edwards, Jane Gallagher, Michael-Rock Goldsmith, Sastry Isukapalli, Rogelio Tornero-Velez, Eric Weber & Robert Kavlock. (2010) Advancing Exposure Characterization for Chemical Evaluation and Risk Assessment. Journal of Toxicology and Environmental Health, Part B 13:2-4, pages 299-313.
Read now
Read now
C. R. Gibson, A. Bergman, P. Lu, F. Kesisoglou, W. S. Denney & E. Mulrooney. (2009) Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling. Xenobiotica 39:9, pages 637-648.
Read now
Read now
Pascal Espié, Dominique Tytgat, Maria-Laura Sargentini-Maier, Italo Poggesi & Jean-Baptiste Watelet. (2009) Physiologically based pharmacokinetics (PBPK). Drug Metabolism Reviews 41:3, pages 391-407.
Read now
Read now
Articles from other publishers (397)
James T. Nguyen, Dan-Dan Tian, Rakshit S. Tanna, Christopher M. Arian, Justina C. Calamia, Allan E. Rettie, Kenneth E. Thummel & Mary F. Paine. (2023) An Integrative Approach to Elucidate Mechanisms Underlying the Pharmacokinetic Goldenseal-Midazolam Interaction: Application of In Vitro Assays and Physiologically Based Pharmacokinetic Models to Understand Clinical Observations. Journal of Pharmacology and Experimental Therapeutics 387:3, pages 252-264.
Crossref
Crossref
Khalil Ben Hassine, Claire Seydoux, Sonia Khier, Youssef Daali, Michael Medinger, Joerg Halter, Dominik Heim, Yves Chalandon, Urs Schanz, Gayathri Nair, Nathan Cantoni, Jakob R Passweg, Chakradhara Rao Satyanarayana Uppugunduri & Marc Ansari. (2023) Pharmacokinetic modeling and simulation with pharmacogenetic insights support the relevance of therapeutic drug monitoring for myeloablative busulfan dosing in adult HSCT.. Transplantation and Cellular Therapy.
Crossref
Crossref
Ben G. Small, Oliver Hatley, Masoud Jamei, Iain Gardner & Trevor N. Johnson. (2023) Incorporation and Performance Verification of Hepatic Portal Blood Flow Shunting in Minimal and Full PBPK Models of Liver Cirrhosis. Clinical Pharmacology & Therapeutics 114:6, pages 1264-1273.
Crossref
Crossref
Flavia Storelli, Mayur K. Ladumor, Xiaomin Liang, Yurong Lai, Paresh P. Chothe, Osatohanmwen J. Enogieru, Raymond Evers & Jashvant D. Unadkat. (2023) Toward improved predictions of pharmacokinetics of transported drugs in hepatic impairment: Insights from the extended clearance model. CPT: Pharmacometrics & Systems Pharmacology.
Crossref
Crossref
Chao Li, Lu Chen, Lixian Li & Wanyi Chen. (2023) Drug-drug interactions and dose management of BTK inhibitors when initiating nirmatrelvir/ritonavir (paxlovid) based on physiologically-based pharmacokinetic models. European Journal of Pharmaceutical Sciences 189, pages 106564.
Crossref
Crossref
Jan Goelen, Gillian Farrell, Jonathan McGeehan, Christopher M. Titman, Nicholas J. W. Rattray, Trevor N. Johnson, Richard D. Horniblow & Hannah K. Batchelor. (2023) Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS/MS proteomics using a QconCAT technique. European Journal of Pharmaceutics and Biopharmaceutics 191, pages 68-77.
Crossref
Crossref
SOWMYA C., ABRAR AHMED H.SURIYA PRAKAASH K. K.. (2023) VIRTUAL BIOEQUIVALENCE IN PHARMACEUTICALS: CURRENT STATUS AND FUTURE PROSPECTS. International Journal of Applied Pharmaceutics, pages 1-9.
Crossref
Crossref
Koichiro Adachi, Masayoshi Utsumi, Tasuku Sato, Hina Nakano, Makiko Shimizu & Hiroshi Yamazaki. (2023) Modeled Rat Hepatic and Plasma Concentrations of Chemicals after Virtual Administrations Using Two Sets of <i>in Silico</i> Liver-to-Plasma Partition Coefficients. Biological and Pharmaceutical Bulletin 46:9, pages 1316-1323.
Crossref
Crossref
Cleo Demeester, Donnia Robins, Angela Elma Edwina, Jos Tournoy, Patrick Augustijns, Ibrahim Ince, Andreas Lehmann, Maria Vertzoni & Jan Frederik Schlender. (2023) Physiologically based pharmacokinetic (PBPK) modelling of oral drug absorption in older adults – an AGePOP review. European Journal of Pharmaceutical Sciences 188, pages 106496.
Crossref
Crossref
Jialin Mao, Fang Ma, Jesse Yu, Tom De Bruyn, Miaoran Ning, Christine Bowman & Yuan Chen. (2023) Shared learning from a physiologically based pharmacokinetic modeling strategy for human pharmacokinetics prediction through retrospective analysis of Genentech compounds. Biopharmaceutics & Drug Disposition 44:4, pages 315-334.
Crossref
Crossref
Dwaipayan Mukherjee, Michelle Collins, Douglas E. Dylla, Jatinder Kaur, Dimitri Semizarov, Anthony Martinez, Brian Conway, Tipu Khan & Nael M. Mostafa. (2023) Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations. Infectious Diseases and Therapy.
Crossref
Crossref
Harvey Clewell, Jerry Campbell & Matthew Linakis. (2023) Recent applications of physiologically based pharmacokinetic modeling to assess the toxicity of mixtures: A review. Current Opinion in Toxicology 34, pages 100390.
Crossref
Crossref
Tom G. Jacobs, Marika A. de Hoop-Sommen, Thomas Nieuwenstein, Joyce E. M. van der Heijden, Saskia N. de Wildt, David M. Burger, Angela Colbers & Jolien J. M. Freriksen. (2023) Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling. Pharmaceutics 15:5, pages 1424.
Crossref
Crossref
Dimitrios I. Fotiadis, Antonis I. Sakellarios & Vassiliki T. Potsika. 2023. Multiscale Modelling in Biomedical Engineering. Multiscale Modelling in Biomedical Engineering
331
354
.
Jieying Lin, Sheng Yuan Chin, Shawn Pei Feng Tan, Hor Cheng Koh, Eleanor Jing Yi Cheong, Eric Chun Yong Chan & James Chun Yip Chan. (2023) Mechanistic Middle-Out Physiologically Based Toxicokinetic Modeling of Transporter-Dependent Disposition of Perfluorooctanoic Acid in Humans. Environmental Science & Technology 57:17, pages 6825-6834.
Crossref
Crossref
Christer Tannergren, Harshad Jadhav, Emma Eckernäs, Jonas Fagerberg, Patrick Augustijns & Erik Sjögren. (2023) Physiologically based biopharmaceutics modeling of regional and colon absorption in humans. European Journal of Pharmaceutics and Biopharmaceutics 186, pages 144-159.
Crossref
Crossref
Agustos C. Ozbey, Fabio Bachmann, Urs Duthaler, Pieter Annaert, Stephen Fowler, Kenichi Umehara, Neil Parrott & Stephan Krähenbühl. (2023) Dose Adjustment in Patients with Liver Cirrhosis – Comparison of Two Different Modeling Approaches. Clinical Pharmacology & Therapeutics.
Crossref
Crossref
Pieter-Jan De Sutter, Pieter De Cock, Trevor N Johnson, Helen Musther, Elke Gasthuys & An Vermeulen. (2023) Predictive Performance of Physiologically Based Pharmacokinetic Modelling of Beta-Lactam Antibiotic Concentrations in Adipose, Bone, and Muscle Tissues. Drug Metabolism and Disposition 51:4, pages 499-508.
Crossref
Crossref
Yogini Dixit, Khushboo Kanojiya, Namrata Bhingardeve, Jayesh J. Ahire & Dina Saroj. (2023) In Vitro Human Gastrointestinal Tract Simulation Systems: A Panoramic Review. Probiotics and Antimicrobial Proteins.
Crossref
Crossref
Min-Soo Kim, Yoo-Kyung Song, Ji-Soo Choi, Hye Young Ji, Eunsuk Yang, Joon Seok Park, Hyung Sik Kim, Min-Joo Kim, In-Kyung Cho, Suk-Jae Chung, Yoon-Jee Chae & Kyeong-Ryoon Lee. (2023) Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans. Pharmaceutics 15:3, pages 942.
Crossref
Crossref
Ji-Hye Nam, Min-Soo Kim, Young-Jo Song, Chang-Hwan Kim, Wang Soo Kim, Chi Ho Yu, Hae Eun Joe, Gyeung Haeng Hur, Myeung-Ryun Seo, Yeongmun Kim, Kyung Eui Park, Jun Young Choi, Suk-Jae Chung & Young Kee Shin. (2023) Pretreatment of rhesus monkeys with transdermal patches containing physostigmine and procyclidine: implications of the delivery system for the potential application against VX nerve agent intoxication in humans. Archives of Toxicology 97:3, pages 697-710.
Crossref
Crossref
Dermot F. McGinnity & Ken Grime. 2023. The Handbook of Medicinal Chemistry. The Handbook of Medicinal Chemistry
298
323
.
Ashley M. Hopkins, Michael J. Sorich, Andrew J. McLachlan, Christos S. Karapetis, John O. Miners, Madelé van Dyk & Andrew Rowland. (2023) Understanding the Risk of Drug Interactions Between Ritonavir-Containing COVID-19 Therapies and Small-Molecule Kinase Inhibitors in Patients With Cancer. JCO Precision Oncology:7.
Crossref
Crossref
Diansong Zhou, Buyun Chen, Shringi Sharma, Weifeng Tang & Xavier Pepin. (2022) Physiologically Based Absorption Modelling to Explore the Formulation and Gastric pH Changes on the Pharmacokinetics of Acalabrutinib. Pharmaceutical Research 40:2, pages 375-386.
Crossref
Crossref
Mayur K. Ladumor, Flavia Storelli, Xiaomin Liang, Yurong Lai, Osatohanmwen J. Enogieru, Paresh P. Chothe, Raymond Evers & Jashvant D. Unadkat. (2022) Predicting changes in the pharmacokinetics of CYP3A‐metabolized drugs in hepatic impairment and insights into factors driving these changes. CPT: Pharmacometrics & Systems Pharmacology 12:2, pages 261-273.
Crossref
Crossref
Martin Gerhards, Alexander Böhme, Kristin Schubert, Bernhard Kodritsch & Nadin Ulrich. (2023) DNA adducts as link between in vitro and in vivo carcinogenicity – A case study with benzo[a]pyrene. Current Research in Toxicology 4, pages 100097.
Crossref
Crossref
Monika Kadian, Garima Sharma, Sandeep Kaur & Anil Kumar. 2023. Handbook of Oncobiology: From Basic to Clinical Sciences. Handbook of Oncobiology: From Basic to Clinical Sciences
1
31
.
Amin Rostami-Hodjegan & Brahim Achour. 2023. Advances in Pharmacokinetics and Pharmacodynamics. Advances in Pharmacokinetics and Pharmacodynamics
137
163
.
Jaidip Gill, Marie Moullet, Anton Martinsson, Filip Miljković, Beth Williamson, Rosalinda H. Arends & Venkatesh Pilla Reddy. (2022) Evaluating the performance of machine‐learning regression models for pharmacokinetic drug–drug interactions. CPT: Pharmacometrics & Systems Pharmacology 12:1, pages 122-134.
Crossref
Crossref
Koichiro Adachi, Makiko Shimizu & Hiroshi Yamazaki. (2022) Updated <i>in Silico</i> Prediction Methods for Fractions Absorbed and Key Input Parameters of 355 Disparate Chemicals for Physiologically Based Pharmacokinetic Models for Time-Dependent Plasma Concentrations after Virtual Oral Doses in Humans. Biological and Pharmaceutical Bulletin 45:12, pages 1812-1817.
Crossref
Crossref
Joyce E. M. van der Heijden, Jolien J. M. Freriksen, Marika A. de Hoop-Sommen, Lianne P. M. van Bussel, Sander H. P. Driessen, Anne E. M. Orlebeke, Laurens F. M. Verscheijden, Rick Greupink & Saskia N. de Wildt. (2022) Feasibility of a Pragmatic PBPK Modeling Approach: Towards Model-Informed Dosing in Pediatric Clinical Care. Clinical Pharmacokinetics 61:12, pages 1705-1717.
Crossref
Crossref
Abdulkarim Najjar, Ans Punt, John Wambaugh, Alicia Paini, Corie Ellison, Styliani Fragki, Enrica Bianchi, Fagen Zhang, Joost Westerhout, Dennis Mueller, Hequn Li, Quan Shi, Timothy W. Gant, Phil Botham, Rémi Bars, Aldert Piersma, Ben van Ravenzwaay & Nynke I. Kramer. (2022) Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment. Archives of Toxicology 96:12, pages 3407-3419.
Crossref
Crossref
Min-Jun Baek, Gyu-Ho Kim, Ju-Hwan Park, Jaehwan Kim, Il-Mo Kang, Jangik I. Lee & Dae-Duk Kim. (2022) Effect of phosphatidylcholine in bentonite-quetiapine complex on enhancing drug release and oral bioavailability. International Journal of Pharmaceutics 628, pages 122347.
Crossref
Crossref
Elena O. Kutumova, Ilya R. Akberdin, Ilya N. Kiselev, Ruslan N. Sharipov, Vera S. Egorova, Anastasiia O. Syrocheva, Alessandro Parodi, Andrey A. ZamyatninJr.Jr. & Fedor A. Kolpakov. (2022) Physiologically Based Pharmacokinetic Modeling of Nanoparticle Biodistribution: A Review of Existing Models, Simulation Software, and Data Analysis Tools. International Journal of Molecular Sciences 23:20, pages 12560.
Crossref
Crossref
Architha Aithal, Shubhrajyotsna Aithal & P. S. Aithal. (2022) Case Study on Certara’s Simcyp PBPK Simulator to Eliminate Lengthy Clinical Trails. International Journal of Health Sciences and Pharmacy, pages 69-109.
Crossref
Crossref
Lu Chen, Chao Li, Hao Bai, Lixian Li & Wanyi Chen. (2022) Use of modeling and simulation to predict the influence of triazole antifungal agents on the pharmacokinetics of zanubrutinib and acalabrutinib. Frontiers in Pharmacology 13.
Crossref
Crossref
Dustin F. Kapraun, Mark Sfeir, Robert G Pearce, Sarah E Davidson-Fritz, Annie Lumen, André Dallmann, Richard S Judson & John F. Wambaugh. (2022) Evaluation of a rapid, generic human gestational dose model. Reproductive Toxicology 113, pages 172-188.
Crossref
Crossref
Jian Lin, Francois Gaudreault, Nathaniel Johnson, Zhiwu Lin, Parya Nouri, Theunis C. Goosen & Aarti Sawant‐Basak. (2022)
Investigation of
CYP3A
induction by
PF
‐05251749 in early clinical development: comparison of linear slope physiologically based pharmacokinetic prediction and biomarker response
. Clinical and Translational Science 15:9, pages 2184-2194.
Crossref
Crossref
Hisham El-Masri, Katie Paul Friedman, Kristin Isaacs & Barbara A. Wetmore. (2022) Advances in computational methods along the exposure to toxicological response paradigm. Toxicology and Applied Pharmacology 450, pages 116141.
Crossref
Crossref
Luna Prieto Garcia, Anna Lundahl, Christine Ahlström, Anna Vildhede, Hans Lennernäs & Erik Sjögren. (2022) Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction. CPT: Pharmacometrics & Systems Pharmacology 11:9, pages 1194-1209.
Crossref
Crossref
Hiba Khalidi, Anthonia Onasanwo, Barira Islam, Heeseung Jo, Ciarán Fisher, Rich Aidley, Iain Gardner & Frederic Y. Bois. (2022) SimRFlow: An R-based workflow for automated high-throughput PBPK simulation with the Simcyp® simulator. Frontiers in Pharmacology 13.
Crossref
Crossref
Yoo-Seong Jeong, Min-Soo Kim & Suk-Jae Chung. (2022) Determination of the Number of Tissue Groups of Kinetically Distinct Transit Time in Whole-Body Physiologically Based Pharmacokinetic (PBPK) Models II: Practical Application of Tissue Lumping Theories for Pharmacokinetics of Various Compounds. The AAPS Journal 24:5.
Crossref
Crossref
Olha Shuklinova, Przemysław Dorożyński, Piotr Kulinowski & Sebastian Polak. (2022) Quality Control Dissolution Data Is Biopredictive for a Modified Release Ropinirole Formulation: Virtual Experiment with the Use of Re-Developed and Verified PBPK Model. Pharmaceutics 14:7, pages 1514.
Crossref
Crossref
Katherine L. Gill & Hannah M. Jones. (2022) Opportunities and Challenges for PBPK Model of mAbs in Paediatrics and Pregnancy. The AAPS Journal 24:4.
Crossref
Crossref
Mian Zhang, Ciarán Fisher, Iain Gardner, Xian Pan, Peter Kilford, Frederic Y. Bois & Masoud Jamei. (2022) Understanding Interindividual Variability in the Drug Interaction of a Highly Extracted CYP1A2 Substrate Tizanidine: Application of a Permeability-Limited Multicompartment Liver Model in a Population Based Physiologically Based Pharmacokinetic Framework. Drug Metabolism and Disposition 50:7, pages 957-967.
Crossref
Crossref
Udoamaka Ezuruike, Mian Zhang, Amita Pansari, Mailys De Sousa Mendes, Xian Pan, Sibylle Neuhoff & Iain Gardner. (2022)
Guide to development of compound files for
PBPK
modeling in the Simcyp population‐based simulator
. CPT: Pharmacometrics & Systems Pharmacology 11:7, pages 805-821.
Crossref
Crossref
Min-Soo Kim, Nora Lee, Areum Lee, Yoon-Jee Chae, Suk-Jae Chung & Kyeong-Ryoon Lee. (2022) Model-Based Prediction of Acid Suppression and Proposal of a New Dosing Regimen of Fexuprazan in Humans. Pharmaceuticals 15:6, pages 709.
Crossref
Crossref
Jingchen Zhai, Beihong Ji, Lianjin Cai, Shuhan Liu, Yuchen Sun & Junmei Wang. (2022) Physiologically-Based Pharmacokinetics Modeling for Hydroxychloroquine as a Treatment for Malaria and Optimized Dosing Regimens for Different Populations. Journal of Personalized Medicine 12:5, pages 796.
Crossref
Crossref
Xiaoqing Chang, Yu-Mei Tan, David G. Allen, Shannon Bell, Paul C. Brown, Lauren Browning, Patricia Ceger, Jeffery Gearhart, Pertti J. Hakkinen, Shruti V. Kabadi, Nicole C. Kleinstreuer, Annie Lumen, Joanna Matheson, Alicia Paini, Heather A. Pangburn, Elijah J. Petersen, Emily N. Reinke, Alexandre J. S. Ribeiro, Nisha Sipes, Lisa M. Sweeney, John F. Wambaugh, Ronald Wange, Barbara A. Wetmore & Moiz Mumtaz. (2022) IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making. Toxics 10:5, pages 232.
Crossref
Crossref
Lu Chen, Ning Ji, Min Zhang & Wanyi Chen. (2022) The Influence of Wuzhi Capsule on the Pharmacokinetics of Cyclophosphamide. Recent Patents on Anti-Cancer Drug Discovery 17:2, pages 195-203.
Crossref
Crossref
Jingchen Zhai, Beihong Ji, Shuhan Liu, Yuzhao Zhang, Lianjin Cai & Junmei Wang. (2022) In Silico Prediction of Pharmacokinetic Profile for Human Oral Drug Candidates Which Lack Clinical Pharmacokinetic Experiment Data. European Journal of Drug Metabolism and Pharmacokinetics 47:3, pages 403-417.
Crossref
Crossref
David E. Hines, Shannon Bell, Xiaoqing Chang, Kamel Mansouri, David Allen & Nicole Kleinstreuer. (2022) Application of an Accessible Interface for Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation. Frontiers in Pharmacology 13.
Crossref
Crossref
Larissa L. Silva, Rebecca M. Silvola, David M. Haas & Sara K. Quinney. (2021) Physiologically based pharmacokinetic modelling in pregnancy: Model reproducibility and external validation. British Journal of Clinical Pharmacology 88:4, pages 1441-1451.
Crossref
Crossref
Tanvi Shroff, Kehinde Aina, Christian Maass, Madalena Cipriano, Joeri Lambrecht, Frank Tacke, Alexander Mosig & Peter Loskill. (2022) Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics. Open Biology 12:3.
Crossref
Crossref
Daniela Rodrigues, Bram Herpers, Sofia Ferreira, Heeseung Jo, Ciarán Fisher, Luke Coyle, Seung-Wook Chung, Jos C. S. Kleinjans, Danyel G. J. Jennen & Theo M. de Kok. (2022) A Transcriptomic Approach to Elucidate the Mechanisms of Gefitinib-Induced Toxicity in Healthy Human Intestinal Organoids. International Journal of Molecular Sciences 23:4, pages 2213.
Crossref
Crossref
Lujing Wang, Yang Chen, Wangda Zhou, Xin Miao & Honghui Zhou. (2021) Utilization of physiologically‐based pharmacokinetic model to assess disease‐mediated therapeutic protein‐disease‐drug interaction in immune‐mediated inflammatory diseases. Clinical and Translational Science 15:2, pages 464-476.
Crossref
Crossref
Xuemei Wu, Xiaohan Zhang, Ruichao Xu, Imam Hussain Shaik & Raman Venkataramanan. (2021) Physiologically based pharmacokinetic modelling of treprostinil after intravenous injection and extended‐release oral tablet administration in healthy volunteers: An extrapolation to other patient populations including patients with hepatic impairment. British Journal of Clinical Pharmacology 88:2, pages 587-599.
Crossref
Crossref
Tomonori Miura, Shotaro Uehara, Makiko Shimizu, Hiroshi Suemizu & Hiroshi Yamazaki. (2022) Forward and reverse dosimetry for aniline and 2,6-dimethylaniline in humans extrapolated from humanized-liver mouse data using simplified physiologically based pharmacokinetic models. The Journal of Toxicological Sciences 47:12, pages 531-538.
Crossref
Crossref
Yusuke Kamiya, Kentaro Handa, Tomonori Miura, Junya Ohori, Airi Kato, Makiko Shimizu, Masato Kitajima & Hiroshi Yamazaki. (2022) Machine Learning Prediction of the Three Main Input Parameters of a Simplified Physiologically Based Pharmacokinetic Model Subsequently Used to Generate Time-Dependent Plasma Concentration Data in Humans after Oral Doses of 212 Disparate Chemicals. Biological and Pharmaceutical Bulletin 45:1, pages 124-128.
Crossref
Crossref
Daisy Arora & Bharat Khurana. 2022. Computer Aided Pharmaceutics and Drug Delivery. Computer Aided Pharmaceutics and Drug Delivery
189
215
.
Yuching Yang & Xinyuan Zhang. 2022. Systems Medicine. Systems Medicine
57
69
.
Camille Lenoir, Amine Niederer, Victoria Rollason, Jules Alexandre Desmeules, Youssef Daali & Caroline Flora Samer. (2021) Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics. CPT: Pharmacometrics & Systems Pharmacology 11:1, pages 30-43.
Crossref
Crossref
Kenneth H. Wills, Stephen J. Behan, Michael J. Nance, Jessica L. Dawson, Thomas M. Polasek, Ashley M. Hopkins, Madelé van Dyk & Andrew Rowland. (2021) Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure. Pharmaceutics 14:1, pages 47.
Crossref
Crossref
Manreet KaurVanessa YardleyKe WangJinit MasaniaRandolph R. J. Arroo, David B. TurnerMingzhong Li. (2021)
Artemisinin Cocrystals for Bioavailability Enhancement. Part 2:
In Vivo
Bioavailability and Physiologically Based Pharmacokinetic Modeling
. Molecular Pharmaceutics 18:12, pages 4272-4289.
Crossref
Crossref
Koichiro Adachi, Satoru Beppu, Mariko Terashima, Toshiaki Fukuda, Jun Tomizawa, Makiko Shimizu & Hiroshi Yamazaki. (2021) Pharmacokinetics of caffeine self-administered in overdose in a Japanese patient admitted to hospital. Journal of Pharmaceutical Health Care and Sciences 7:1.
Crossref
Crossref
Koichiro Adachi, Yuki Sugitani, Ryo Unita, Kosuke Yoshida, Satoru Beppu, Mariko Terashima, Masaya Fujii, Makiko Shimizu & Hiroshi Yamazaki. (2021) Pharmacokinetics of loxoprofen in a self-administered overdose in a Japanese patient admitted to hospital. Journal of Pharmaceutical Health Care and Sciences 7:1.
Crossref
Crossref
Koichiro Adachi, Satoru Beppu, Mariko Terashima, Wataru Kobari, Makiko Shimizu & Hiroshi Yamazaki. (2021) Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital. Journal of Pharmaceutical Health Care and Sciences 7:1.
Crossref
Crossref
Mariana Guimarães, Pascal Somville, Maria Vertzoni & Nikoletta Fotaki. (2021) Investigating the Critical Variables of Azithromycin Oral Absorption Using In Vitro Tests and PBPK Modeling. Journal of Pharmaceutical Sciences 110:12, pages 3874-3888.
Crossref
Crossref
Ashit Trivedi, Winnie Sohn, Priyanka Kulkarni, Pegah Jafarinasabian, Hanze Zhang, Marintan Spring, Stephen Flach, Siddique Abbasi, Jan Wahlstrom, Edward Lee & Sandeep Dutta. (2021) Evaluation of drug‐drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically‐based pharmacokinetic model. Clinical and Translational Science 14:6, pages 2510-2520.
Crossref
Crossref
David E Hines, Jingjie Zhang, Xiaoqing Chang, Shannon M. Bell & K. Monica Lee. (2021) Application of open-source PBPK models in rat-to-human pharmacokinetic extrapolation of oral nicotine exposure. Computational Toxicology 20, pages 100182.
Crossref
Crossref
Chang‑Keun Cho, Pureum Kang, Hye-Jung Park, Yun Jeong Lee, Jung‑Woo Bae, Choon-Gon Jang & Seok-Yong Lee. (2021) Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele. Archives of Pharmacal Research 44:11, pages 1037-1049.
Crossref
Crossref
Hyeon‐Cheol Jeong, Yoon‐Jee Chae, Sooyeun Lee, Wonku Kang, Hwi‐yeol Yun & Kwang‐Hee Shin. (2021) Prediction of Fluoxetine and Norfluoxetine Pharmacokinetic Profiles Using Physiologically Based Pharmacokinetic Modeling. The Journal of Clinical Pharmacology 61:11, pages 1505-1513.
Crossref
Crossref
Sundus Khalid, Muhammad Fawad Rasool, Imran Imran, Abdul Majeed, Hamid Saeed, Anees ur Rehman, Waseem Ashraf, Tanveer Ahmad, Yousef A. Bin Jardan & Faleh Alqahtani. (2021) A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications. Pharmaceutics 13:9, pages 1480.
Crossref
Crossref
Jahnavi Kharidia, Eleanor M. Howgate, Celine M. Laffont, Yongzhen Liu & Malcolm A. Young. (2021) Evaluation of Drug‐Drug Interaction Liability for Buprenorphine Extended‐Release Monthly Injection Administered by Subcutaneous Route. Clinical Pharmacology in Drug Development 10:9, pages 1064-1074.
Crossref
Crossref
Chie Emoto, Makiko Shimizu, Toshihiro Tanaka & Hiroshi Yamazaki. (2021) Feasibility of physiologically based pharmacokinetic simulations for assessing pediatric patients after accidental drug ingestion: A case study of a 1.4-year-old girl who ingested alprazolam. Drug Metabolism and Pharmacokinetics 39, pages 100394.
Crossref
Crossref
Chie Emoto, Trevor N. Johnson, Takaaki Yamada, Hiroshi Yamazaki & Tsuyoshi Fukuda. (2021) Teicoplanin physiologically based pharmacokinetic modeling offers a quantitative assessment of a theoretical influence of serum albumin and renal function on its disposition. European Journal of Clinical Pharmacology 77:8, pages 1157-1168.
Crossref
Crossref
Grigoris I. Grigoriadis, Vasileios C. Pezoulas, Maria Roumpi, George Gkois, Nikolaos S. Tachos, Momcilo Prodanovic, Danica Prodanovic, Boban Stojanovic, Srboljub M. Mijailovich, Nenad Filipovic & Dimitrios I. Fotiadis. (2021) Towards the development of a unified virtual population model in hypertrophic cardiomyopathy. Towards the development of a unified virtual population model in hypertrophic cardiomyopathy.
Bret BernerWojciech Krzyzanski. 2021. Drug Delivery Approaches. Drug Delivery Approaches
75
97
.
Anusha Balla, Yoo-Seong Jeong, Hyo-Jung Kim, Yun-Jong Lee, Suk-Jae Chung, Yoon-Jee Chae & Han-Joo Maeng. (2021) Effects of 1α,25-Dihydroxyvitamin D3 on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in Rats with PBPK Modeling Approach. Pharmaceutics 13:8, pages 1133.
Crossref
Crossref
Imran Shah, Todor Antonijevic, Bryant Chambers, Joshua Harrill & Russell Thomas. (2021) Estimating Hepatotoxic Doses Using High-Content Imaging in Primary Hepatocytes. Toxicological Sciences.
Crossref
Crossref
Armin Sadighi, Lorenzo Leggio & Fatemeh Akhlaghi. (2021) Development of a Physiologically Based Pharmacokinetic Model for Prediction of Ethanol Concentration-Time Profile in Different Organs. Alcohol and Alcoholism 56:4, pages 401-414.
Crossref
Crossref
Yoo-Seong Jeong & William J. Jusko. (2021) Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species. Pharmaceuticals 14:6, pages 545.
Crossref
Crossref
Fuyin Zheng, Yuminghao Xiao, Hui Liu, Yubo Fan & Ming Dao. (2021) Patient‐Specific Organoid and Organ‐on‐a‐Chip: 3D Cell‐Culture Meets 3D Printing and Numerical Simulation. Advanced Biology 5:6.
Crossref
Crossref
Yoo-Seong Jeong, Min-Soo Kim, Nora Lee, Areum Lee, Yoon-Jee Chae, Suk-Jae Chung & Kyeong-Ryoon Lee. (2021) Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans. Pharmaceutics 13:6, pages 813.
Crossref
Crossref
Takashi Ueno, Yukiko Miyajima, Ishani Landry, Bojan Lalovic & Edgar Schuck. (2021) Physiologically‐based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors. CPT: Pharmacometrics & Systems Pharmacology 10:5, pages 455-466.
Crossref
Crossref
Muhammad F. Rasool, Shazia Ali, Sundus Khalid, Ramsha Khalid, Abdul Majeed, Imran Imran, Hamid Saeed, Muhammad Usman, Mohsin Ali, Amer S. Alali, Abdullah F. AlAsmari, Nemat Ali, Ali Mohammed Asiri, Fawaz Alasmari & Faleh Alqahtani. (2021) Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases. Scientific Reports 11:1.
Crossref
Crossref
Emma Eckernäs & Christer Tannergren. (2021) Physiologically Based Biopharmaceutics Modeling of Regional and Colon Absorption in Dogs. Molecular Pharmaceutics 18:4, pages 1699-1710.
Crossref
Crossref
Vamshi Krishna Jogiraju, Tycho Heimbach, Yuliana Toderika & David R. Taft. (2021) Physiologically based pharmacokinetic modeling of altered tizanidine systemic exposure by CYP1A2 modulation: Impact of drug-drug interactions and cigarette consumption. Drug Metabolism and Pharmacokinetics 37, pages 100375.
Crossref
Crossref
Donald J. Irby, Mustafa E. Ibrahim, Anees M. Dauki, Mohamed A. Badawi, Sílvia M. Illamola, Mingqing Chen, Yuhuan Wang, Xiaoxi Liu, Mitch A. Phelps & Diane R. Mould. (2021) Approaches to handling missing or “problematic” pharmacology data: Pharmacokinetics. CPT: Pharmacometrics & Systems Pharmacology 10:4, pages 291-308.
Crossref
Crossref
Karim Azer, Chanchala D. Kaddi, Jeffrey S. Barrett, Jane P. F. Bai, Sean T. McQuade, Nathaniel J. Merrill, Benedetto Piccoli, Susana Neves-Zaph, Luca Marchetti, Rosario Lombardo, Silvia Parolo, Selva Rupa Christinal Immanuel & Nitin S. Baliga. (2021) History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications. Frontiers in Physiology 12.
Crossref
Crossref
Shahinaze A. Fouad, Fady A. Malaak, Mohamed A. El-Nabarawi, Khalid Abu Zeid & Amira M. Ghoneim. (2021) Preparation of solid dispersion systems for enhanced dissolution of poorly water soluble diacerein: In-vitro evaluation, optimization and physiologically based pharmacokinetic modeling. PLOS ONE 16:1, pages e0245482.
Crossref
Crossref
Mayu Yanagi, Yusuke Kamiya, Norie Murayama, Kaito Banju, Makiko Shimizu & Hiroshi Yamazaki. (2021) Metabolic profiles for the pyrrolizidine alkaloid neopetasitenine and its metabolite petasitenine in humans extrapolated from rat <i>in vivo</i> and <i>in vitro</i> data sets using a simplified physiologically based pharmacokinetic model. The Journal of Toxicological Sciences 46:9, pages 391-399.
Crossref
Crossref
Mitsuo Higashimori, Kensuke Ishikawa, Michael Gillen & Diansong Zhou. (2021) Physiologically Based Pharmacokinetic Modelling of Glycopyrronium in Patients With Renal Impairment. Journal of Pharmaceutical Sciences 110:1, pages 438-445.
Crossref
Crossref
Anneke Himstedt, Per Bäckman & Jens Markus Borghardt. 2021. Inhaled Medicines. Inhaled Medicines
319
358
.
Christopher R. Gibson, Ying-Hong Wang, Ninad Varkhede & Bennett Ma. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
443
479
.
Cheng Cui, Xiaobei Li, Hao Liang, Zhe Hou, Siqi Tu, Zhongqi Dong, Xueting Yao, Miao Zhang, Xuan Zhang, Haiyan Li, Xiaocong Zuo & Dongyang Liu. (2021) Physiologically based pharmacokinetic model of renally cleared antibacterial drugs in Chinese renal impairment patients. Biopharmaceutics & Drug Disposition 42:1, pages 24-34.
Crossref
Crossref
Koichiro Adachi, Jumpei Tuchiya, Satoru Beppu, Kei Nishiyama, Makiko Shimizu & Hiroshi Yamazaki. (2020) Pharmacokinetics of anticoagulant edoxaban in overdose in a Japanese patient transported to hospital. Journal of Pharmaceutical Health Care and Sciences 6:1.
Crossref
Crossref
Manuel Ibarra, Marta Vázquez & Pietro Fagiolino. (2020) Current PBPK Models: Are They Predicting Tissue Drug Concentration Correctly?. Drugs in R&D 20:4, pages 295-299.
Crossref
Crossref
Susanna Tse, Martin E. Dowty, Sujatha Menon, Pankaj Gupta & Sriram Krishnaswami. (2020) Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug Exposure and Support Dosing Recommendations for Potential Drug‐Drug Interactions or in Special Populations: An Example Using Tofacitinib. The Journal of Clinical Pharmacology 60:12, pages 1617-1628.
Crossref
Crossref
Mingzhe Shen, Maozi Chen, Tianjian Liang, Siyi Wang, Ying Xue, Richard Bertz, Xiang-Qun Xie & Zhiwei Feng. (2020) Pain Chemogenomics Knowledgebase (Pain-CKB) for Systems Pharmacology Target Mapping and Physiologically Based Pharmacokinetic Modeling Investigation of Opioid Drug–Drug Interactions. ACS Chemical Neuroscience 11:20, pages 3245-3258.
Crossref
Crossref
Fengxu Wu, Yuquan Zhou, Langhui Li, Xianhuan Shen, Ganying Chen, Xiaoqing Wang, Xianyang Liang, Mengyuan Tan & Zunnan Huang. (2020) Computational Approaches in Preclinical Studies on Drug Discovery and Development. Frontiers in Chemistry 8.
Crossref
Crossref
Ioannis Loisios-Konstantinidis, Bart Hens, Amitava Mitra, Sarah Kim, Chang Chiann & Rodrigo Cristofoletti. (2020) Using Physiologically Based Pharmacokinetic Modeling to Assess the Risks of Failing Bioequivalence Criteria: a Tale of Two Ibuprofen Products. The AAPS Journal 22:5.
Crossref
Crossref
Edgar Schuck, Jim Ferry, Barry Gidal & Ziad Hussein. (2020) Changes in perampanel levels during de‐induction: Simulations following carbamazepine discontinuation. Acta Neurologica Scandinavica 142:2, pages 131-138.
Crossref
Crossref
Manoranjenni Chetty, Michael P. Danckwerts & Andrea Julsing. (2020) Prediction of the exposure to a 400-mg daily dose of efavirenz in pregnancy: is this dose adequate in extensive metabolisers of CYP2B6?. European Journal of Clinical Pharmacology 76:8, pages 1143-1150.
Crossref
Crossref
Michael Davies, Rhys D.O. Jones, Ken Grime, Rasmus Jansson-Löfmark, Adrian J. Fretland, Susanne Winiwarter, Paul Morgan & Dermot F. McGinnity. (2020) Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades. Trends in Pharmacological Sciences 41:6, pages 390-408.
Crossref
Crossref
Yuki Notsu, Makiko Shimizu, Tatsuro Sasaki, Ayane Nakano, Miki Ota, Sayaka Yoshida & Hiroshi Yamazaki. (2020) Simple pharmacokinetic models accounting for drug monitoring results of atomoxetine and its 4-hydroxylated metabolites in Japanese pediatric patients genotyped for cytochrome P450 2D6. Drug Metabolism and Pharmacokinetics 35:2, pages 191-200.
Crossref
Crossref
Khaled Abduljalil, Xian Pan, Amita Pansari, Masoud Jamei & Trevor N. Johnson. (2019) Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population. Clinical Pharmacokinetics 59:4, pages 501-518.
Crossref
Crossref
Khaled Abduljalil, Xian Pan, Amita Pansari, Masoud Jamei & Trevor N. Johnson. (2019) A Preterm Physiologically Based Pharmacokinetic Model. Part I: Physiological Parameters and Model Building. Clinical Pharmacokinetics 59:4, pages 485-500.
Crossref
Crossref
Francois Pierre Combes, Heidi J. Einolf, Neva Coello, Tycho Heimbach, Handan He & Kai Grosch. (2020) Model‐Informed Drug Development for Everolimus Dosing Selection in Pediatric Infant Patients. CPT: Pharmacometrics & Systems Pharmacology 9:4, pages 230-237.
Crossref
Crossref
Xuemei Wu, Hongfei Zhang, Mohammad Kowser Miah, Steve N. Caritis & Raman Venkataramanan. (2019) Physiologically Based Pharmacokinetic Approach Can Successfully Predict Pharmacokinetics of Citalopram in Different Patient Populations. The Journal of Clinical Pharmacology 60:4, pages 477-488.
Crossref
Crossref
Brooks T. McPhail, Chie Emoto, Tsuyoshi Fukuda, Dawn Butler, Jason R. Wiles, Henry Akinbi & Alexander A. Vinks. (2019) Utilizing Pediatric Physiologically Based Pharmacokinetic Models to Examine Factors That Contribute to Methadone Pharmacokinetic Variability in Neonatal Abstinence Syndrome Patients. The Journal of Clinical Pharmacology 60:4, pages 453-465.
Crossref
Crossref
Naoya Matsumura, Shun Hayashi, Yoshiyuki Akiyama, Asami Ono, Satoko Funaki, Naomi Tamura, Takahiro Kimoto, Maiko Jiko, Yuka Haruna, Akiko Sarashina, Masahiro Ishida, Kotaro Nishiyama, Masahiro Fushimi, Yukiko Kojima, Kazuhiro Yoneda, Misato Nakanishi, Soonih Kim, Takuya Fujita & Kiyohiko Sugano. (2020) Prediction Characteristics of Oral Absorption Simulation Software Evaluated Using Structurally Diverse Low-Solubility Drugs. Journal of Pharmaceutical Sciences 109:3, pages 1403-1416.
Crossref
Crossref
Robert A. Beckman, Irina Kareva & Frederick R. Adler. (2020) How Should Cancer Models Be Constructed?. Cancer Control 27:1, pages 107327482096200.
Crossref
Crossref
Andrzej Przekwas & Mahadevabharath R. Somayaji. 2020. Organ-on-a-chip. Organ-on-a-chip
311
361
.
Jan Wahlstrom & Larry Wienkers. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
847
866
.
John F Wambaugh, Barbara A Wetmore, Caroline L Ring, Chantel I Nicolas, Robert G Pearce, Gregory S Honda, Roger Dinallo, Derek Angus, Jon Gilbert, Teresa Sierra, Akshay Badrinarayanan, Bradley Snodgrass, Adam Brockman, Chris Strock, R Woodrow Setzer & Russell S Thomas. (2019) Assessing Toxicokinetic Uncertainty and Variability in Risk Prioritization. Toxicological Sciences 172:2, pages 235-251.
Crossref
Crossref
Muhammad F. Rasool, Sundus Khalid, Abdul Majeed, Hamid Saeed, Imran Imran, Mohamed Mohany, Salim S. Al-Rejaie & Faleh Alqahtani. (2019) Development and Evaluation of Physiologically Based Pharmacokinetic Drug–Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations. Pharmaceutics 11:11, pages 578.
Crossref
Crossref
Jeremy A. Leonard & Yu-Mei Tan. (2019) Tiered approaches for screening and prioritizing chemicals through integration of pharmacokinetics and exposure information with in vitro dose-response data. Computational Toxicology 12, pages 100101.
Crossref
Crossref
Jian Lin, Theunis C. Goosen, Susanna Tse, Hidetomi Yamagami & Bimal Malhotra. (2019) Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug‐Drug Interaction for Fesoterodine When Coadministered With Mirabegron. The Journal of Clinical Pharmacology 59:11, pages 1505-1518.
Crossref
Crossref
Izna Ali, Daniel Guidone, Joseph A. Nicolazzo & Kim L.R. Brouwer. (2019) Impact of reduced P‐glycoprotein function on digoxin concentrations in patients with dementia. British Journal of Clinical Pharmacology 85:10, pages 2351-2359.
Crossref
Crossref
Asha J Kapetas, Michael J Sorich, A David Rodrigues & Andrew Rowland. (2019) Guidance for Rifampin and Midazolam Dosing Protocols To Study Intestinal and Hepatic Cytochrome P450 (CYP) 3A4 Induction and De-induction. The AAPS Journal 21:5.
Crossref
Crossref
Shinji Yamazaki, Chester Costales, Sarah Lazzaro, Soraya Eatemadpour, Emi Kimoto & Manthena V. Varma. (2019) Physiologically‐Based Pharmacokinetic Modeling Approach to Predict Rifampin‐Mediated Intestinal P‐Glycoprotein Induction. CPT: Pharmacometrics & Systems Pharmacology 8:9, pages 634-642.
Crossref
Crossref
Blessy Joseph, Anish Narasimhan Gomatam, Mushtaque A. S. Shaikh, Vijay Khedkar, Elvis A. F. Martis & Evans Clifton Coutinho. (2019) Eigen Value ANalySis (EVANS) ‒ A Tool to Address Pharmacodynamic, Pharmacokinetic and Toxicity Issues. International Journal of Quantitative Structure-Property Relationships 4:3, pages 118-136.
Crossref
Crossref
Diansong Zhou, Terry Podoll, Yan Xu, Ganesh Moorthy, Karthick Vishwanathan, Joseph Ware, J. Greg Slatter & Nidal Al‐Huniti. (2019)
Evaluation of the Drug–Drug Interaction Potential of Acalabrutinib and Its Active Metabolite,
ACP
‐5862, Using a
Physiologically‐Based Pharmacokinetic
Modeling Approach
. CPT: Pharmacometrics & Systems Pharmacology 8:7, pages 489-499.
Crossref
Crossref
Felix Stader, Melissa A. Penny, Marco Siccardi & Catia Marzolini. (2019) A Comprehensive Framework for Physiologically‐Based Pharmacokinetic Modeling in Matlab. CPT: Pharmacometrics & Systems Pharmacology 8:7, pages 444-459.
Crossref
Crossref
Laurens F. M. Verscheijden, Jan B. Koenderink, Saskia N. de Wildt & Frans G. M. Russel. (2019) Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis. PLOS Computational Biology 15:6, pages e1007117.
Crossref
Crossref
Philippe B. Pierrillas, Emilie Henin, Kathryn Ball, Julien Ogier, Magali Amiel, Laurence Kraus-Berthier, Marylore Chenel, François Bouzom & Michel Tod. (2019) Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation Strategy. Drug Metabolism and Disposition 47:6, pages 648-656.
Crossref
Crossref
Ly Ly Pham, Thomas Y. Sheffield, Prachi Pradeep, Jason Brown, Derik E. Haggard, John Wambaugh, Richard S. Judson & Katie Paul Friedman. (2019) Estimating uncertainty in the context of new approach methodologies for potential use in chemical safety evaluation. Current Opinion in Toxicology 15, pages 40-47.
Crossref
Crossref
Michael J. Sorich, Fayzah Mutlib, Madelé van Dyk, Ashley M. Hopkins, Thomas M. Polasek, Jean‐Claude Marshall, A. David Rodrigues & Andrew Rowland. (2019) Use of Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Axitinib Exposure: A Fresh Approach to Precision Dosing in Oncology. The Journal of Clinical Pharmacology 59:6, pages 872-879.
Crossref
Crossref
Thomas M. Polasek, Craig R. Rayner, Richard W. Peck, Andrew Rowland, Holly Kimko & Amin Rostami‐Hodjegan. (2018) Toward Dynamic Prescribing Information: Codevelopment of Companion Model‐Informed Precision Dosing Tools in Drug Development. Clinical Pharmacology in Drug Development 8:4, pages 418-425.
Crossref
Crossref
Kentaro Konishi, Tsuyoshi Minematsu, Yasuhisa Nagasaka & Kenji Tabata. (2019) Application of a physiologically based pharmacokinetic model for the prediction of mirabegron plasma concentrations in a population with severe renal impairment. Biopharmaceutics & Drug Disposition 40:5-6, pages 176-187.
Crossref
Crossref
Yoo-Seong Jeong, Anusha Balla, Kwang-Hoon Chun, Suk-Jae Chung & Han-Joo Maeng. (2019) Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and N-Acetylprocainamide with Cimetidine, an Inhibitor of rOCT2 and rMATE1, in Rats. Pharmaceutics 11:3, pages 108.
Crossref
Crossref
Yongjun Hu & David E. Smith. (2019)
In Silico Prediction of the Absorption and Disposition of Cefadroxil in Humans using an Intestinal Permeability Method Scaled from Humanized
PepT1
Mice
. Drug Metabolism and Disposition 47:3, pages 173-183.
Crossref
Crossref
Takanobu Matsuzaki, Daniel Scotcher, Adam S. Darwich, Aleksandra Galetin & Amin Rostami-Hodjegan. (2019) Towards Further Verification of Physiologically-Based Kidney Models: Predictability of the Effects of Urine-Flow and Urine-pH on Renal Clearance. Journal of Pharmacology and Experimental Therapeutics 368:2, pages 157-168.
Crossref
Crossref
Hidetoshi Shimizu, Kosuke Yoshida, Tomohisa Nakada, Koki Kojima, Akihito Ogasawara, Yoshinobu Nakamaru & Hiroshi Yamazaki. (2019) Prediction of Human Distribution Volumes of Compounds in Various Elimination Phases Using Physiologically Based Pharmacokinetic Modeling and Experimental Pharmacokinetics in Animals. Drug Metabolism and Disposition 47:2, pages 114-123.
Crossref
Crossref
Ying‐Hong Wang, Dapeng Chen, Georgy Hartmann, Carolyn R. Cho & Karsten Menzel. (2018) PBPK Modeling Strategy for Predicting Complex Drug Interactions of Letermovir as a Perpetrator in Support of Product Labeling. Clinical Pharmacology & Therapeutics 105:2, pages 515-523.
Crossref
Crossref
Emilio S. Petito, David J.R. Foster, Michael B. Ward & Matthew J. Sykes. (2019) Molecular Modeling Approaches for the Prediction of Selected Pharmacokinetic Properties. Current Topics in Medicinal Chemistry 18:26, pages 2230-2238.
Crossref
Crossref
Huybrecht T’jollyn, An Vermeulen & Jan Van Bocxlaer. (2018) PBPK and its Virtual Populations: the Impact of Physiology on Pediatric Pharmacokinetic Predictions of Tramadol. The AAPS Journal 21:1.
Crossref
Crossref
Elaine A. Cohen Hubal, Barbara A. Wetmore, John F. Wambaugh, Hisham El-Masri, Jon R. Sobus & Tina Bahadori. (2018) Advancing internal exposure and physiologically-based toxicokinetic modeling for 21st-century risk assessments. Journal of Exposure Science & Environmental Epidemiology 29:1, pages 11-20.
Crossref
Crossref
Shruthi Vaidhyanathan, Xiaoning Wang, John Crison, Sailesh Varia, Julia Z.H. Gao, Ajay Saxena & David Good. (2019) Bioequivalence Comparison of Pediatric Dasatinib Formulations and Elucidation of Absorption Mechanisms Through Integrated PBPK Modeling. Journal of Pharmaceutical Sciences 108:1, pages 741-749.
Crossref
Crossref
Venkatesh Pilla Reddy, Khanh Bui, Graeme Scarfe, Diansong Zhou & Maria Learoyd. (2018) Physiologically Based Pharmacokinetic Modeling for Olaparib Dosing Recommendations: Bridging Formulations, Drug Interactions, and Patient Populations. Clinical Pharmacology & Therapeutics 105:1, pages 229-241.
Crossref
Crossref
Jeremy Burrows, Hannah Slater, Fiona Macintyre, Sarah Rees, Anna Thomas, Fredros Okumu, Rob Hooft van Huijsduijnen, Stephan Duparc & Timothy N. C. Wells. (2018) A discovery and development roadmap for new endectocidal transmission-blocking agents in malaria. Malaria Journal 17:1.
Crossref
Crossref
Robin Michelet, Jan Van Bocxlaer, Karel Allegaert & An Vermeulen. (2018) The use of PBPK modeling across the pediatric age range using propofol as a case. Journal of Pharmacokinetics and Pharmacodynamics 45:6, pages 765-785.
Crossref
Crossref
Andrew Rowland, Madelé van Dyk, Ashley M. Hopkins, Reham Mounzer, Thomas M. Polasek, Amin Rostami‐Hodjegan & Michael J. Sorich. (2018) Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Drug Exposure. Clinical Pharmacology & Therapeutics 104:6, pages 1219-1228.
Crossref
Crossref
Salim Bouchene, Sandrine Marchand, William Couet, Lena E. Friberg, Patrice Gobin, Isabelle Lamarche, Nicolas Grégoire, Sven Björkman & Mats O. Karlsson. (2018) A Whole-Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat. Basic & Clinical Pharmacology & Toxicology 123:4, pages 407-422.
Crossref
Crossref
Michele Fedecostante, Koen G. C. Westphal, Michele F. Buono, Natalia Sanchez Romero, Martijn J. Wilmer, Janis Kerkering, Pedro Miguel Baptista, Joost G. Hoenderop & Rosalinde Masereeuw. (2018) Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening. Drug Metabolism and Disposition 46:9, pages 1338-1350.
Crossref
Crossref
Luis G. Valerio Jr.*. 2018. Early Drug Development. Early Drug Development
549
580
.
Ulf Bredberg. 2018. Early Drug Development. Early Drug Development
399
432
.
Shinji Yamazaki, Cho-Ming Loi, Emi Kimoto, Chester Costales & Manthena V. Varma. (2018) Application of Physiologically Based Pharmacokinetic Modeling in Understanding Bosutinib Drug-Drug Interactions: Importance of Intestinal P-Glycoprotein. Drug Metabolism and Disposition 46:8, pages 1200-1211.
Crossref
Crossref
Shinji Yamazaki. (2018) Relationships of Changes in Pharmacokinetic Parameters of Substrate Drugs in Drug-Drug Interactions on Metabolizing Enzymes and Transporters. The Journal of Clinical Pharmacology 58:8, pages 1053-1060.
Crossref
Crossref
Jason W Boland, Miriam Johnson, Diana Ferreira & David J Berry. (2018) In silico (computed) modelling of doses and dosing regimens associated with morphine levels above international legal driving limits. Palliative Medicine 32:7, pages 1222-1232.
Crossref
Crossref
Yoshiaki Yao, Kota Toshimoto, Soo-Jin Kim, Takashi Yoshikado & Yuichi Sugiyama. (2018) Quantitative Analysis of Complex Drug-Drug Interactions between Cerivastatin and Metabolism/Transport Inhibitors Using Physiologically Based Pharmacokinetic Modeling. Drug Metabolism and Disposition 46:7, pages 924-933.
Crossref
Crossref
Zaril Zakaria & Raj K.S. Badhan. (2018) The impact of CYP2B6 polymorphisms on the interactions of efavirenz with lumefantrine: Implications for paediatric antimalarial therapy. European Journal of Pharmaceutical Sciences 119, pages 90-101.
Crossref
Crossref
Wangda Zhou, Trevor N. Johnson, Khanh H. Bui, S.Y. Amy Cheung, Jianguo Li, Hongmei Xu, Nidal Al-Huniti & Diansong Zhou. (2018) Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children. Clinical Pharmacology & Therapeutics 104:1, pages 188-200.
Crossref
Crossref
Jiachang Gong, Lisa Iacono, Ramaswamy A. Iyer, William G. Humphreys & Ming Zheng. (2018) Physiologically-based pharmacokinetic modelling of a CYP2C19 substrate, BMS-823778, utilizing pharmacogenetic data. British Journal of Clinical Pharmacology 84:6, pages 1335-1345.
Crossref
Crossref
Dwaipayan Mukherjee, Jiuhong Zha, Rajeev M. Menon & Mohamad Shebley. (2018) Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic model. Journal of Pharmacokinetics and Pharmacodynamics 45:3, pages 443-456.
Crossref
Crossref
John F Wambaugh, Michael F Hughes, Caroline L Ring, Denise K MacMillan, Jermaine Ford, Timothy R Fennell, Sherry R Black, Rodney W Snyder, Nisha S Sipes, Barbara A Wetmore, Joost Westerhout, R Woodrow Setzer, Robert G Pearce, Jane Ellen Simmons & Russell S Thomas. (2018) Evaluating In Vitro-In Vivo Extrapolation of Toxicokinetics. Toxicological Sciences 163:1, pages 152-169.
Crossref
Crossref
Venkatesh Pilla Reddy, Michael Walker, Pradeep Sharma, Peter Ballard & Karthick Vishwanathan. (2018) Development, Verification, and Prediction of Osimertinib Drug–Drug Interactions Using PBPK Modeling Approach to Inform Drug Label. CPT: Pharmacometrics & Systems Pharmacology 7:5, pages 321-330.
Crossref
Crossref
Yi Jin, Hubert Borell, Anne Gardin, Mike Ufer, Felix Huth & Gian Camenisch. (2017) In vitro studies and in silico predictions of fluconazole and CYP2C9 genetic polymorphism impact on siponimod metabolism and pharmacokinetics. European Journal of Clinical Pharmacology 74:4, pages 455-464.
Crossref
Crossref
Chie Emoto, Trevor N. Johnson, Brooks T. McPhail, Alexander A. Vinks & Tsuyoshi Fukuda. (2018) Using a Vancomycin PBPK Model in Special Populations to Elucidate Case‐Based Clinical PK Observations. CPT: Pharmacometrics & Systems Pharmacology 7:4, pages 237-250.
Crossref
Crossref
Thomas M. Polasek, Geoffrey T. Tucker, Michael J. Sorich, Michael D. Wiese, Titus Mohan, Amin Rostami-Hodjegan, Porntipa Korprasertthaworn, Vidya Perera & Andrew Rowland. (2018) Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation. British Journal of Clinical Pharmacology 84:3, pages 462-476.
Crossref
Crossref
Tao Liu & Jogarao V.S. Gobburu. (2018) A Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug-Drug Interactions of Buprenorphine After Subcutaneous Administration of CAM2038 With Perpetrators of CYP3A4. Journal of Pharmaceutical Sciences 107:3, pages 942-948.
Crossref
Crossref
Shannon M. Bell, Xiaoqing Chang, John F. Wambaugh, David G. Allen, Mike Bartels, Kim L.R. Brouwer, Warren M. Casey, Neepa Choksi, Stephen S. Ferguson, Grazyna Fraczkiewicz, Annie M. Jarabek, Alice Ke, Annie Lumen, Scott G. Lynn, Alicia Paini, Paul S. Price, Caroline Ring, Ted W. Simon, Nisha S. Sipes, Catherine S. Sprankle, Judy Strickland, John Troutman, Barbara A. Wetmore & Nicole C. Kleinstreuer. (2018) In vitro to in vivo extrapolation for high throughput prioritization and decision making. Toxicology in Vitro 47, pages 213-227.
Crossref
Crossref
Ka Lai Yee, Mengyao Li, Tamara Cabalu, Vaishali Sahasrabudhe, Jian Lin, Ping Zhao & Pravin Jadhav. (2017) Evaluation of Model‐Based Prediction of Pharmacokinetics in the Renal Impairment Population. The Journal of Clinical Pharmacology 58:3, pages 364-376.
Crossref
Crossref
C-H Hsueh, V Hsu, P Zhao, L Zhang, KM Giacomini & S-M Huang. (2018) PBPK Modeling of the Effect of Reduced Kidney Function on the Pharmacokinetics of Drugs Excreted Renally by Organic Anion Transporters. Clinical Pharmacology & Therapeutics 103:3, pages 485-492.
Crossref
Crossref
Maria D. Donovan, Khaled Abduljalil, John F. Cryan, Geraldine B. Boylan & Brendan T. Griffin. (2018) Application of a physiologically-based pharmacokinetic model for the prediction of bumetanide plasma and brain concentrations in the neonate. Biopharmaceutics & Drug Disposition 39:3, pages 125-134.
Crossref
Crossref
Andrea Flynn & Elizabeth Fox. (2018) Evolving paradigms for new agent development in pediatric oncology. Current Opinion in Pediatrics 30:1, pages 10-16.
Crossref
Crossref
Holly M. Mortensen, John Chamberlin, Bonnie Joubert, Michelle Angrish, Nisha Sipes, Janice S. Lee & Susan Y. Euling. (2018) Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment. Mammalian Genome 29:1-2, pages 190-204.
Crossref
Crossref
Emily Schwenger, Venkatesh Pilla Reddy, Ganesh Moorthy, Pradeep Sharma, Helen Tomkinson, Eric Masson & Karthick Vishwanathan. (2018) Harnessing Meta-analysis to Refine an Oncology Patient Population for Physiology-Based Pharmacokinetic Modeling of Drugs. Clinical Pharmacology & Therapeutics 103:2, pages 271-280.
Crossref
Crossref
Nikunjkumar Patel, Barbara Wiśniowska, Masoud Jamei & Sebastian Polak. (2017) Real Patient and its Virtual Twin: Application of Quantitative Systems Toxicology Modelling in the Cardiac Safety Assessment of Citalopram. The AAPS Journal 20:1.
Crossref
Crossref
Kannan Krishnan. 2018. Handbook of Developmental Neurotoxicology. Handbook of Developmental Neurotoxicology
539
557
.
Huybrecht T’jollyn, An Vermeulen, Jan Van Bocxlaer & Pieter Colin. (2017) A Physiologically Based Pharmacokinetic Perspective on the Clinical Utility of Albumin-Based Dose Adjustments in Critically Ill Patients. Clinical Pharmacokinetics 57:1, pages 59-69.
Crossref
Crossref
Angela Effinger, Caitriona M. O’Driscoll, Mark McAllister & Nikoletta Fotaki. 2018. ADME Processes in Pharmaceutical Sciences. ADME Processes in Pharmaceutical Sciences
301
330
.
Jan Wahlstrom & Larry Wienkers. 2018. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1
20
.
Caifu Xue, Xunjie Zhang & Weimin Cai. (2017) Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model. Pharmaceutics 10:1, pages 1.
Crossref
Crossref
Shriram M. Pathak, Aaron Ruff, Edmund S. Kostewicz, Nikunjkumar Patel, David B. Turner & Masoud Jamei. (2017)
Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated
in Vitro in Vivo
Extrapolation Perspective Using Ketoconazole as a Model Drug
. Molecular Pharmaceutics 14:12, pages 4305-4320.
Crossref
Crossref
Displaying 200 of 421 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list